BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12622261)

  • 21. Gastrointestinal complications and meloxicam.
    Fenn GC; Morant SV; Shield MJ
    Br J Rheumatol; 1997 Nov; 36(11):1234. PubMed ID: 9402874
    [No Abstract]   [Full Text] [Related]  

  • 22. In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological media.
    Hirayama F; Minami K; Uekama K
    J Pharm Pharmacol; 1996 Jan; 48(1):27-31. PubMed ID: 8722490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-inflammatory, analgesic and ulcerogenic properties of S-(+)-ibuproxam, racemic ibuproxam-beta-cyclodextrin and S-(+)-ibuproxam-beta-cyclodextrin.
    Bole-Vunduk B; Verhnjak K; Zmitek J
    J Pharm Pharmacol; 1996 Nov; 48(11):1153-7. PubMed ID: 8961164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoscopy of the gastroduodenal mucosa after carprofen, meloxicam and ketoprofen administration in dogs.
    Forsyth SF; Guilford WG; Haslett SJ; Godfrey J
    J Small Anim Pract; 1998 Sep; 39(9):421-4. PubMed ID: 9791828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of cyclodextrin complexation with NSAIDs on NSAID/cold stress-induced gastric ulceration in rats.
    Alsarra IA; Ahmed MO; Alanazi FK; Eltahir KE; Alsheikh AM; Neau SH
    Int J Med Sci; 2010 Jul; 7(4):232-9. PubMed ID: 20617127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of psoriasis after meloxicam.
    Ilknur T; Fetil E; Akarsu S; Arda F; Sis B; Günes AT
    Eur J Dermatol; 2006; 16(4):444-5. PubMed ID: 16935809
    [No Abstract]   [Full Text] [Related]  

  • 27. Syntheses and evaluation of anti-inflammatory, analgesic and ulcerogenic activities of 1,3,4-oxadiazole and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives.
    Chawla G; Kumar U; Bawa S; Kumar J
    J Enzyme Inhib Med Chem; 2012 Oct; 27(5):658-65. PubMed ID: 21899490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the analgesic and anti-inflammatory activities of some thiazolo[4,5-d]pyrimidines.
    Balkan A; Gören Z; Urgun H; Caliş U; Cakar AN; Atilla P; Uzbay T
    Arzneimittelforschung; 2002; 52(6):462-7. PubMed ID: 12109047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of 4-biphenylacetic acid bioavailability in rats by its beta-cyclodextrin complex after oral administration.
    Puglisi G; Santagati NA; Ventura CA; Pignatello R; Panico AM; Spampinato S
    J Pharm Pharmacol; 1991 Jun; 43(6):430-2. PubMed ID: 1681057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of meloxicam on the haemostatic profile of dogs undergoing orthopaedic surgery.
    Kazakos GM; Papazoglou LG; Rallis T; Tsimopoulos G; Adamama-Moraitou K; Tea A
    Vet Rec; 2005 Oct; 157(15):444-6. PubMed ID: 16215245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy and tolerance of meloxicam in dogs with chronic osteoarthritis.
    Doig PA; Purbrick KA; Hare JE; McKeown DB
    Can Vet J; 2000 Apr; 41(4):296-300. PubMed ID: 10769766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Upper digestive hemorrhage caused by meloxicam].
    del Val A; Llorente MJ; Tenías JM; Lluch A
    Rev Esp Enferm Dig; 1998 Jun; 90(6):461-2. PubMed ID: 9708012
    [No Abstract]   [Full Text] [Related]  

  • 33. Meloxicam-induced pulmonary infiltrates with eosinophilia: a case report.
    Karakatsani A; Chroneou A; Koulouris NG; Orphanidou D; Jordanoglou J
    Rheumatology (Oxford); 2003 Sep; 42(9):1112-3. PubMed ID: 12923267
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-inflammatory and gastro sparing activity of some new indomethacin derivatives.
    Amir M; Kumar S
    Arch Pharm (Weinheim); 2005 Jan; 338(1):24-31. PubMed ID: 15674801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrocyclic molecules and their pharmacological applications.
    Lasagna L
    Eur J Rheumatol Inflamm; 1993; 12(4):3-5. PubMed ID: 7805702
    [No Abstract]   [Full Text] [Related]  

  • 36. Inclusion Complexes of Non-Steroidal Anti-Inflammatory Drugs with Cyclodextrins: A Systematic Review.
    Miranda GM; Santos VORE; Bessa JR; Teles YCF; Yahouédéhou SCMA; Goncalves MS; Ribeiro-Filho J
    Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33673414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meloxicam and meloxicam-beta-cyclodextrin complex in model membranes: effects on the properties and enzymatic lipolysis of phospholipid monolayers in relation to anti-inflammatory activity.
    Wiecław K; Korchowiec B; Corvis Y; Korchowiec J; Guermouche H; Rogalska E
    Langmuir; 2009 Feb; 25(3):1417-26. PubMed ID: 19123793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic anti-inflammatory interaction between meloxicam and aminoguanidine hydrochloride in carrageenan-induced acute inflammation in rats.
    Dudhgaonkar SP; Tandan SK; Bhat AS; Jadhav SH; Kumar D
    Life Sci; 2006 Feb; 78(10):1044-8. PubMed ID: 16109432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meloxicam-induced erythema multiforme.
    Nikas SN; Kittas G; Karamaounas N; Drosos AA
    Am J Med; 1999 Nov; 107(5):532-4. PubMed ID: 10569318
    [No Abstract]   [Full Text] [Related]  

  • 40. A possible anaphylactoid reaction in a cow after intravenous meloxicam.
    Okushima S; Chesnel MA; Clutton RE
    Vet Anaesth Analg; 2013 May; 40(3):333-4. PubMed ID: 23438083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.